4.5 Article

Disruptive Mood Dysregulation Disorder: Symptomatic and Syndromic Thresholds and Diagnostic Operationalization

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jaac.2019.12.008

Keywords

child/adolescent; developmental psychopathology; disruptive mood dysregulation disorder; irritability; temper outbursts

Funding

  1. Associacao Brasileira de Saude Coletiva (ABRASCO-Brazilian Association of Public Health)
  2. Wellcome Trust (United Kingdom)
  3. Sao Paulo Research FoundationeFAPESP [2014/13864-6]
  4. World Health Organization
  5. Programa de Apoio a Nucleos de Excele. ncia (PRONEXeSupport Program for Excellence Centers)
  6. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPqe National Council for Scientific and Technological Development)
  7. Brazilian Ministry of Health
  8. Pastoral da Crianca (Child's Pastoral)
  9. NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002786] Funding Source: NIH RePORTER

Ask authors/readers for more resources

This study aimed to identify the most appropriate threshold for DMDD diagnosis and assess the impact of potential changes in diagnostic rules on prevalence levels. Results showed that symptoms of irritable mood and outburst varied at different thresholds, leading to the determination of the best DMDD criteria with a prevalence rate of 3%.
Objective: To identify the most appropriate threshold for disruptive mood dysregulation disorder (DMDD) diagnosis and the impact of potential changes in diagnostic rules on prevalence levels in the community. Method: Trained psychologists evaluated 3,562 preadolescents/early adolescents from the 2004 Pelotas Birth Cohort with the Development and Well-Being Behavior Assessment (DAWBA). The clinical threshold was assessed in 3 stages: symptomatic, syndromic, and clinical operationalization. The symptomatic threshold identified the response category in each DAWBA item, which separates normative misbehavior from a clinical indicator. The syndromic threshold identified the number of irritable mood and outbursts needed to capture preadolescents/early adolescents with high symptom levels. Clinical operationalization compared the impact of AND/OR rules for combining irritable mood and outbursts on impairment and levels of psychopathology. Results: At the symptomatic threshold, most irritable mood items were normative in their lowest response categories and clinically significant in their highest response categories. For outbursts, some indicated a symptom even when present at only a mild level, while others did not indicate symptoms at any level. At the syndromic level, a combination of 2 out of 7 irritable mood and 3 out of 8 outburst indicators accurately captured a cluster of individuals with high level of symptoms. Analysis combining irritable mood and outbursts delineated nonoverlapping aspects of DMDD, providing support for the OR rule in clinical operationalization. The best DMDD criteria resulted in a prevalence of 3%. Conclusion: Results provide information for initiatives aiming to provide data-driven and clinically oriented operationalized criteria for DMDD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available